Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells. (2023)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000909
PubMed Identifier: 37304935
Publication URI: http://europepmc.org/abstract/MED/37304935
Type: Journal Article/Review
Volume: 7
Parent Publication: HemaSphere
Issue: 6
ISSN: 2572-9241